Literature DB >> 22074208

Disparities in reproductive health-related visits to the emergency department in Maryland by age and race, 1999-2005.

Shanna Cox1, Teresa Dean, Samuel F Posner, Denise J Jamieson, Kathryn M Curtis, Christopher H Johnson, Susan Meikle.   

Abstract

OBJECTIVE: To describe reproductive health-related visits to Maryland emergency departments (EDs) among women aged 15-44 years from 1999 to 2005.
METHODS: We obtained data from the Healthcare Cost and Utilization Project State Emergency Department Database and State Inpatient Database. ICD-9-CM diagnosis codes were used to classify reproductive health-related visits. We calculated the annual rate of reproductive health visits to Maryland EDs from 1999 to 2005 for women aged 15-44 years and tested time trends using linear regression. Admission rates were defined as the percentage of ED visits that resulted in inpatient admission. We calculated age-specific and race-specific rate ratios for diagnoses using Poisson regression and admission rate ratios using Cochran-Mantel-Haenszel statistics.
RESULTS: From 1999 to 2005, the rate of ED visits in Maryland increased 50%, from 28.0 to 42.1 visits per 1000 women. Lower genital tract infections were the most common diagnosis (21.4%). The rates were higher for women aged 15-24 than for women aged 25-44 (rate ratio 1.18, 95% confidence interval [CI] 1.17-1.18) and nearly three times higher for black women than white women (rate ratio 2.94, 95% CI 2.92-2.96). Admission rates were lower for women aged 15-24 than for women aged 25-44 (rate ratio 0.34, 95% CI 0.33-0.35) and were higher among black than white women (rate ratio 1.16, 95% CI 1.14-1.18).
CONCLUSIONS: Disparities by age and race are evident for reproductive health-related ED visits in Maryland, and many of these ED visits are for conditions that are amenable to preventive measures.

Entities:  

Mesh:

Year:  2011        PMID: 22074208     DOI: 10.1089/jwh.2010.2554

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  2 in total

1.  Characteristics and costs of multidrug-resistant tuberculosis in-patient care in the United States, 2005-2007.

Authors:  S M Marks; Y Hirsch-Moverman; K Salcedo; E A Graviss; P Oh; B Seaworth; J Flood; L Armstrong; L Armitige; S Mase
Journal:  Int J Tuberc Lung Dis       Date:  2016-04       Impact factor: 2.373

Review 2.  Pelvic inflammatory disease: improving awareness, prevention, and treatment.

Authors:  Breanne B Das; Jocelyn Ronda; Maria Trent
Journal:  Infect Drug Resist       Date:  2016-08-19       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.